Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-4.87%Gross Profits to Assets
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - GPA Historical data
| Date | Total Assets | Gross Profit | Gross Profits to Assets |
|---|---|---|---|
| 6/30/2025 | $ 25.79M | $ -1.25M | -4.87% |
| 3/31/2025 | $ 38.57M | $ -226K | -0.59% |
| 12/31/2024 | $ 38.34M | $ 123K | 0.32% |
| 9/30/2024 | $ 48.89M | $ 250K | 0.51% |
| 6/30/2024 | $ 65.44M | $ 1.03M | 1.58% |
| 3/31/2024 | $ 82.32M | $ 424K | 0.52% |
| 12/31/2023 | $ 73.7M | $ 120K | 0.16% |
| 9/30/2023 | $ 100.45M | $ 686K | 0.68% |
| 6/30/2023 | $ 140.1M | $ 983K | 0.7% |
| 3/31/2023 | $ 180.1M | $ 552K | 0.31% |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 0%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average GPA has been -0.02%.
- The median GPA for BIOXCEL THERAPEUTICS INC during this period was 0.03%
- BIOXCEL THERAPEUTICS INC reached its highest GPA over the past 5 years at 1.58%.
- The lowest GPA recorded by BIOXCEL THERAPEUTICS INC in the same timeframe -4.87%
BIOXCEL THERAPEUTICS INC's GPA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GPA Benchmarks
Similar metrics to GPA:
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Asset Turnover - [Calculation] The Asset Turnover ratio measures how effective a company uses its assets to generate revenue. It is calculated as [Revenue] divided by [Assets].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Gross Profit - [Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Definition of Gross Profits to Assets
[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].GP / Assets
(=) GPA GPA for BIOXCEL THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 238.75M ]
(=) GPA [ 0% ] BTAI - Gross Profits to Assets, Last 5 years
-4.87%
Minimum
Jun 30, 2025
1.58%
Maximum
Jun 30, 2024
-0.02%
Average
0.03%
Median
GPA Benchmark AnalysisMarket
The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.94%.
The following table provides additional summary stats:
GPA in the Market:
| filtered constituents | 4.13K |
|---|---|
| min | -50.32% |
| max | 84.08% |
| average | 20.16% |
| median | 15.34% |
| std | 19.94% |